Stock Events

Stock Events

Corvus Pharmaceuticals (CRVS) Q3 2024 Earnings

6AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.14

-0.12

-0.09

-0.07

Details

Expected EPS

-0.115

Actual EPS

-0.07

Surprise EPS

0.05

Surprise Percent

+39.13%

Description

Corvus Pharmaceuticals (CRVS) has reported earnings of -0.07 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.